Hide Board Information

Show Board Information

Dbxt MSCI Emene 1Cc ETF XMEY

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:31 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Dbxt MSCI Emene 1Cc ETF (XMEY) Stock Message Board

Find XMEY Recent News, XMEY Filings, XMEY Stock Quote, XMEY Stock Chart, XMEY Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Dbxt MSCI Emene 1Cc ETF XMEY

Recent Articles

• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
• Remitly to Showcase Innovations at Upcoming TMT Summit
• Dana Incorporates Leadership Change Amid Strategic Transformation
• Lexicon Pharmaceuticals Announces Upcoming December Investor Events
• Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
• NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
• ORIC Pharmaceuticals Enhances Visibility at December Conferences
• LanzaTech Welcomes Thierry Pilenko to Board of Directors
• Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
• EMP Metals Secures $3 Million Loan Agreement with Tembo
• Leslies Experiences Financial Challenges in Latest Earnings
• Dana Incorporates Strategic Changes to Boost Growth and Value
• Fluence Energy Delivers Impressive Q4 Results and Growth Insights
• StealthGas Reports Impressive Q3 Earnings Growth
• Analyzing PennantPark Floating Rate's Q4 Earnings Results
• Insights on Pennant Park Investment's Latest Earnings Report
• Central Garden & Pet Reports Improved Q4 Earnings Results
• Enanta Pharma Reports Strong Q4 Earnings Surprising Analysts
• Woodward's Impressive Earnings Surge: Insights and Guidance
• Blue Bird's Q4 Earnings Report: Insights and Analysis
• Overview of New Jersey Resources' Recent Earnings Report
• Central Garden & Pet Surprises Investors with Earnings Report
• Enanta Pharma Reports Promising Q4 Earnings Highlights
• Blue Bird Faces Earnings Challenge: A Detailed Overview